AdamChristopherElNaggarMDMD(He/Him)

PubMed

• Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial.
  Friedman, C., D'Souza, A., Bello Roufai, D., Tinker, A., de Miguel, M., Gambardella, V., Goldman, J., Loi, S., Melisko, M., Oaknin, A., Spanggaard, I., Shapiro, G., El...> ;Gynecologic Oncology. 2024 Feb 1
• 1 citations
  Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032).
  Leslie M Randall, David M O'Malley, Bradley J Monk, Robert L Coleman, Stephanie Gaillard, Sarah Adams, Linda R Duska, Heather Dalton, Robert W Holloway, Marilyn Huang,...> ;Gynecologic Oncology. 2023 Nov 1
• 4 citations
  DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma.
  Rebecca Arend, Jhalak Dholakia, Cesar Castro, Ursula Matulonis, Erika Hamilton, Camille Gunderson Jackson, Kristopher LyBarger, Howard M Goodman, Linda R Duska, Haider...> ;Gynecologic Oncology. 2023 May 1
• 2 citations
  Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma.
  Sarah A Ackroyd, David Arguello, Pilar Ramos, Haider Mahdi, Adam ElNaggar, Ira Winer, Rob Holloway, Thomas Krivak, Nathaniel Jones, Valerie Galvan Turner, Thomas Herzo...> ;Gynecologic Oncology. 2023 Feb 1
• 8 citations
  Genomic profiling in low grade serous ovarian cancer: Identification of novel markers for disease diagnosis and therapy.
  Adam ElNaggar, David Robins, Yasmine Baca, David Arguello, Michael Ulm, Rebecca Arend, Gina Mantia-Smaldone, Christina Chu, Ira Winer, Rob Holloway, Tom Krivak, Nathan...> ;Gynecologic Oncology. 2022 Nov 1
• 2 citations
  Clinical outcomes in patients with COVID-19 and gynecologic cancer: A society of gynecologic oncology COVID-19 and gynecologic cancer registry study.
  Gretchen E Glaser, Olivia D Lara, Bhavana Pothuri, Carolina Gomez Grimaldi, Lauren S Prescott, Spyridon A Mastroyannis, Sarah Kim, Adam C ElNaggar, Diogo Torres, Lesle...> ;Gynecologic Oncology. 2022 Nov 1
• 9 citations
  Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis.
  Karen Cadoo, Fiona Simpkins, Cara Mathews, Ying L Liu, Diane Provencher, Colleen McCormick, Adam C ElNaggar, Alon D Altman, Lucy Gilbert, Destin Black, Nashwa Kabil, J...> ;Gynecologic Oncology. 2022 Sep 1
• 9 citations
  Molecular profiles of endometrial cancer tumors among Black patients.
  Annelise M Wilhite, Yasmine Baca, Joanne Xiu, Rajesh Paladugu, Adam C ElNaggar, Jubilee Brown, Ira S Winer, Robert Morris, Britt K Erickson, Alexander B Olawaiye, Matt...> ;Gynecologic Oncology. 2022 Jul 1
• Radiofrequency and microwave ablation for treatment of recurrent gynecologic malignancies.
  Naixin Zhang, Catherine Coffman, Ben Wilson, Joann Gold, Scott Baum, Todd Tillmanns, Adam ElNaggar> ;International Journal of Gynecological Cancer. 2022 Jun 9
• 4 citations
  Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer.
  Daniel Simmons, Stephanie V Blank, Adam C ElNaggar, Benjamin Chastek, Scott H Bunner, Kimmie McLaurin> ;Advances in Therapy. 2022 Jun 1
• Response to anti-DKK1 therapy in uterine carcinosarcoma: A case report.
  A ElNaggar, N Zhang, C B Scalise, C Sirard, M H Kagey, D Vaena, R Arend> ;Gynecologic Oncology Reports. 2022 Feb 1
• 5 citations
  Same-day discharge after robotic surgery for endometrial cancer.
  Naixin Zhang, Ben R Wilson, Morgan A. Enty, Peter Ketch, Michael A. Ulm, Adam C. ElNaggar, L.R. Daily, Todd Tillmanns> ;Journal of Robotic Surgery. 2021 Jul 8
• 18 citations
  Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting.
  Ari M. Vanderwalde, Axel Grothey, Daniel Vaena, Gregory A. Vidal, Adam C. ElNaggar, Gabriella Bufalino, Lee S. Schwartzberg> ;Journal of Personalized Medicine. 2020 Nov 27
• 3 citations
  Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer
  Michael A. Ulm, Tiffany Redfern, Ben R Wilson, Suriyan Ponnusamy, Sarah Asemota, Patrick Blackburn, Yinan Wang, Adam C. ElNaggar, Ramesh Narayanan> ;Journal of Personalized Medicine. 2020 Nov 26
• 170 citations
  NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.
  Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Lisa Barroilhet, Kian Behbakht, Andrew Berchuck, Jonathan S. Berek, Lee-may Chen, Mihaela C. Cristea, M...> ;Journal of the National Comprehensive Cancer Network. 2019 Aug 1
• 35 citations
  Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial.
  Ana Oaknin, Claire F. Friedman, Lynda D. Roman, Anishka D'souza, Irene Brana, François-Clément Bidard, Jonathan H. Goldman, Edwin A. Alvarez, Valentina Boni, Adam C. E...> ;Gynecologic Oncology. 2019 Jun 1
• 10 citations
  Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center.
  Adam C. ElNaggar, David M. O'Malley, Margaret I. Liang, Larry J. Copeland, Jeffrey M. Fowler, Ritu Salani, Floor J. Backes, David E. Cohn> ;Gynecologic Oncology. 2017 Jun 1
• 10 citations
  Celecoxib versus ketorolac following robotic hysterectomy for the management of postoperative pain: An open-label randomized control trial.
  Michael A. Ulm, Adam C. ElNaggar, Todd Tillmanns> ;Gynecologic Oncology. 2018 Oct 1
• 2 citations
  Recurrent low grade serous ovarian cancer in a 20 year old woman: A case from the Ohio State University College of Medicine
  David E. Cohn, Floor J. Backes, John J. Wallbillich, Kristin Bixel, Sarah M. Crafton, Robert Neff, Adam C. ElNaggar, Blair Smith, Adrian A. Suarez> ;Gynecologic Oncology. 2017 Mar 1
• 92 citations
  Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target
  Uksha Saini, Shan Naidu, Adam C. ElNaggar, Hemant K. Bid, John J. Wallbillich, Kristin Bixel, Chelsea Bolyard, Adrian A. Suarez, Balveen Kaur, Periannan Kuppusamy, Joh...> ;Oncogene. 2017 Jan 12
• 18 citations
  Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective Cohort.
  Floor J. Backes, Adam C. ElNaggar, Michael Ryan Farrell, Lorna A. Brudie, Sarfraz Ahmad, Ritu Salani, David E. Cohn, Robert W. Holloway, Jeffrey M. Fowler, David M. O'...> ;International Journal of Gynecological Cancer. 2016 Nov 1
• 13 citations
  Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancer.
  Adam C. ElNaggar, Uksha Saini, Shan Naidu, Ross Wanner, Millie Sudhakar, John Fowler, Masaki Nagane, Periannan Kuppusamy, David E. Cohn, Karuppaiyah Selvendiran> ;Cancer Biology & Therapy. 2016 Jul 14
• 2 citations
  Incidence and contributing factors to termination of the patient-physician relationship
  Joseph T. Santoso, Edmundo Yibirin, Mary Crigger, Jim Y. Wan, Adam C. ElNaggar> ;Gynecologic Oncology Reports. 2016 Aug 1
• 4 citations
  Addition of Everolimus Post VEGFR Inhibition Treatment Failure in Advanced Sarcoma Patients Who Previously Benefited from VEGFR Inhibition: A Case Series.
  Adam C. ElNaggar, John L. Hays, James L. Chen> ;Plos One. 2016 Jun 13
• 16 citations
  Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients
  Katherine Fuh, Angeles Alvarez Secord, Kerri S. Bevis, Warner K. Huh, Adam C. ElNaggar, Kevin Blansit, Rebecca A. Previs, Todd Tillmanns, Daniel S. Kapp, John K. Chan> ;Gynecologic Oncology. 2015 Dec 1
• Join now to see all

Journal Articles

• A Comparison of Outcomes following Robotic-Assisted Staging and Laparotomy in patients with Early Stage Endometrioid Adenocarcinoma of the Uterus with Uterine Weight U...  
  Ulm, M.A., Ginn, D.N., ElNaggar, A.C., Tillmanns, T.D., Reed, K.M., Wan, J.Y., Watson, C.H., Dedania, S.J., Reed, M.E., Gynecology and Minimally Invasive Therapy, 1/1/2016
• "Effect of Transdermal Scopolamine for the Prevention of Postoperative Nausea and Vomiting Associated With Robotic Gynecologic Surgery: A Randomized, Double-Blinded, P...  
  Lee, D., Tillmanns, T.D., Ulm, M., Mabe, A., Kumar, S., ElNaggar, A.C., Journal of Gynecologic Surgery, 1/1/2015

Abstracts/Posters

• Close vulvar cancer margins are not strongly associated with recurrence or survival.
  C. Cosgrove, A. ElNaggar, M. Ulm, R. Sarin, E. Hade, P. Blackburn, T. Tillmanns, M. Reed, D. Cohn, J. Fowler., Featured Posters I & II: Meet the Professor Reception: Connecting Minds for a Better Future, Society of Gynecologic Oncology Annual Meeting, National Harbor, MD, 1/1/2017
• Neo-adjuvant chemotherapy for the treatment of stage IV endometrial adenocarcinoma: A retrospective cohort.
  A. ElNaggar, R. Neff, M. Ulm, L. Lambrecht, U. Naeem, S. Pollock, J. Fowler, D. Cohn, F. Backes, T. Tillmanns, Featured Posters I & II: Meet the Professor Reception: Connecting Minds for a Better Future, Society of Gynecologic Oncology Annual Meeting, National Harbor, MD, 1/1/2017
• Recurrence in obese patients with stage I endometrioid endometrial cancer: Does para-aortic lymph node dissection matter?
  C. Watson, A. ElNaggar, T. Tillmanns, M. Ulm, Featured Posters I & II: Meet the Professor Reception: Connecting Minds for a Better Future, Society of Gynecologic Oncology Annual Meeting, National Harbor, MD, 1/1/2017
• Radiofrequency ablation for the treatment of recurrent gynecological malignancies: A case series.
  C. Coffman, A. ElNaggar, A. Talbot, C. Carr, S. Baum, T. Tillmanns, Society of Gynecologic Oncology Annual Meeting, National Harbor, MD, 1/1/2017
• Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a national cancer institute-designated comprehensive cancer center.
  A. ElNaggar, M. Liang, E. Hade, L. Copeland, J. Fowler, R. Salani, F. Backes, D. O'Malley, D. Cohn, Society of Gynecologic Oncology Annual Meeting, National Harbor, MD, 1/1/2017
• Postoperative opioids: Are physicians prescribing more than what is necessary for adequate pain control?
  L. Daily, M. Ulm, A. ElNaggar, T. Tillmanns, Society of Gynecologic Oncology Annual Meeting, National Harbor, MD, 1/1/2017
• A Multi-Institutional Analysis of Surgery and Chemotherapy for Stage IVB Carcinosarcoma of the Uterus.
  Vandersluis, A., Wade, K.S., Ding, K., Backes, F., Cosgrove, C., ElNaggar, A.C., Richardson, D., Roane, B, Erickson, B., Leath, C.A., Moore, K.N., Gunderson, C.C., SGO Winter Meeting, Breckenridge, CO, 1/1/2017
• Elevated STAT3 expression in ovarian tumor ascites regulates invasion and metastasis: a promising therapeutic target.
  Saini, U., Naidu, S., ElNaggar, A., Heman, B., Wallbillich, J., Wanner, R., Bixel, K., Riley, M. Bolyard, C., Suarez, A. Kaur, B., Kuppusamy, P., Hays, J., Goodfellow,..., Late-Breaking Research: Tumor Biology 1; Section 11, American Association for Cancer Research Annual Meeting, New Orleans, LA, 1/1/2016
• HO-3867, a selective inhibitor of stat3, suppress ovarian tumor growth and metastasis in human tissue culture and in an orthotopic mouse model.
  Naidu, S., Saini, U., ElNaggar, A., Heman, B., Wanner, R., Bixel, K., Suarez, A., Bolyard, C., Kaur, B., Goodfellow, P., Kuppusamy, P., Cohn, D., Selvendiran, K., Cancer Research, American Association for Cancer Research Annual Meeting, Philadelphia, PA, 1/1/2015
• Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute (NCI)-designated Comprehensive Cancer Center (CCC).
  Liang, M., ElNaggar, A., Nekkanti, S., O'Malley, D., Hade, E., Copeland, L., Fowler, J., Salani, R., Backes, F., Cohn, D., Gynecologic Oncology, Featured Poster. Society of Gynecologic Oncology 46th Annual Meeting on Women's Cancer, Chicago, IL, 1/1/2015
• Utility of intraoperative frozen section of the inguinofemoral sentinel lymph node in vulvar cancer: a retrospective cohort.
  ElNaggar, A., Coffman, C., Davis, E., Duncan, M., Reed, M., Gynecologic Oncology, Society of Gynecologic Oncology 46th Annual Meeting on Women's Cancer, Chicago, IL, 1/1/2015
• Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and HO-4318, in ovarian cancer.
  ElNaggar, A., Naidu, S., Saini, U., Wanner, R., Sudhakar, E., Cohn, D., Selvendiran, K., Gynecologic Oncology, Society of Gynecologic Oncology 46th Annual Meeting on Women's Cancer, Chicago, IL, 1/1/2015
• Suppression of ovarian cancer growth and metastasis with HO-3867, a STAT3 inhibitor, in human tissue culture and in an orthotopic mouse model.
  Naidu, S., Saini, U., ElNaggar, A., Rath, K., Heman, B., Lata, P., Wanner, R., Sudhakar, E., Hideg, K., Suarez, A., Hays, J., Houghton, P., Goodfellow, P., Cohn, D., S..., Gynecologic Oncology, Society of Gynecologic Oncology 46th Annual Meeting on Women's Cancer, Chicago, IL, 1/1/2015
• A comparison of progression free survival and postoperative outcomes for early stage endometrioid adenocarcinoma following robotic-assisted staging and laparotomy.
  Ulm, M., Ginn, D., ElNaggar, A., Tillmanns, T., Reed, K., Watson, C., Dedania, S., Reed, M., Gynecologic Oncology, Society of Gynecologic Oncology 46th Annual Meeting on Women's Cancer, Chicago, IL, 1/1/2015
• The effects of obesity on robotic-assisted pelvic and periaortic node sampling in endometrial cancer.
  Reed, K., Ulm, M., ElNaggar, A., Tillmanns, T., Reed, M., Gynecologic Oncology, Society of Gynecologic Oncology 46th Annual Meeting on Women's Cancer, Chicago, IL, 1/1/2015
• Targeting constitutively-activated STAT3 in hypoxic ovarian cancer.
  McCann, G., ElNaggar, A., Naidu, S., Rath, K., Tierney, B., Suarez, A., Cohn, D., Selvendiran, K., Clin Cancer Res, Marsha Rivkin Center for Ovarian Cancer Research and the American Association for Cancer Research 10th Biennial Ovarian Cancer Research Symposium, Seattle, WA, 2014, 1/1/2015
• High Resolution Anoscopy for the Detection of Anal Intraepithelial Neoplasia.
  ElNaggar, A.C., Likes, W., Gynecologic Oncology, Focused Plenary: Surgical Film Session, Society of Gynecologic Oncology 45th Annual Meeting, Tampa Bay, FL, 1/1/2014
• Suppression of ovarian tumor growth and metastasis with a STAT3 inhibitor, HO-3867, in preclinical orthotopic models and ex vivo cultures of ovarian cancer.
  Naidu, S., Saini, U., ElNaggar, A., Rath, KS, Hemant, BK, Lata, P., Wanner, R., Sudhakar, E., Hideg, K., Hays, J., Houghton, P., Goodfellow, PJ, Cohn, DE, Selvendiran, K., Cancer Research, The Ohio State University 16th Annual Scientific Meeting, American Association for Cancer Research Annual Meeting, Columbus, OH, 2014; San Diego, CA, 2014, 1/1/2014
• Risk Factors for Anal Intraepithelial Neoplasia.
  ElNaggar, A., Kumar, S., Santoso, J., Gynecologic Oncology, Western Association Gynecologic Oncologist & Felix Rutledge Society Annual Meeting, Huntington Beach, CA, 1/1/2012
• Trends of bevacizumab use and toxicity in advanced ovarian cancer over the last 7 years: A multi-institutional study.
  Chapman, J., Fuh, K., Alvarez-Secord, A., Huh, W., Tillmanns, T., Moore, K., Bevis, K., Polin, M., ElNaggar, A., Chan, J., Gynecologic Oncology, Society for Gynecologic Oncology Annual Meeting, Austin, TX, 1/1/2012
• The efficacy and safety of chemotherapy in combination with bevacizumab vs. bevacizumab alone in recurrent epithelial ovarian cancer-A multi-institutional study .
  Fuh, K., Secord, A., Huh, W., Tillmanns, T., Moore, K., Bevis, K., ElNaggar, A., Previs, R., Kiet, T., Chan, J., Gynecologic Oncology, Society for Gynecologic Oncology Annual Meeting, Austin, TX, 1/1/2012
• Outcomes of ovarian cancer patients after bevacizumab and chemotherapy in primary vs. recurrent setting – A multi-institutional study.
  Chan, J., Secord, A., Tillmanns, T., Moore, K., Bevis, K., ElNaggar, A., Perry, L., McClung, C., Tian, C., Huh, W., Gynecologic Oncology, Society for Gynecologic Oncology Annual Meeting, Austin, TX, 1/1/2012
• Guided Outcomes in Learned Efficiency (GOLE) Model of Medical Education: A Prospective Randomized Controlled Trial.
  Patil A., ElNaggar, A.C., Tillmanns, T., CREOG/APGO, Orlando, FL, 1/1/2012
• Team Climate Inventory as a Tool to Assess Provider Dynamics in an Academic Outpatient Clinic.
  Patil, A., ElNaggar, A.C., Shephard, C., Duke Medicine 6th Annual Patient Safety & Quality Conference, Durham, NC, 1/1/2010
• Neo-adjuvant chemotherapy followed by TAH BSO lymph node dissection vs. TAH BSO lymph node dissection followed by chemotherapy for Stage III-IV epithelial endometrial ...
  Lambrecht, L., ElNaggar, A.C., Kumar, S., Tillmanns, T., Western Association of Gynecologic Oncologists, Santa Barbara, CA, 1/1/2010
• Join now to see all

Lectures

• A randomized controlled trial comparing the efficacy of perioperative celecoxib versus ketorolac for perioperative pain control. 
  National Harbor, MD - 1/1/2017
• "Ovarian Cancer: Update on Screening" 
  Memphis, TN - 1/1/2017
• "Prevention of Lower Genital Tract Malignancies" 
  Grant Medical Center, Columbus, OH - 1/1/2016
• "Current management of gestational trophoblastic disease" 
  Columbus, OH - 1/1/2016
• Gynecologic malignancies. 
  The Ohio State University-Wexner Medical Center, Columbus, OH - 1/1/2015
• "CREOG Review: Lower Genital Tract disease and GTD" 
  The Ohio State University-Wexner Medical Center, Columbus, OH - 1/1/2015
• Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and HO-4318, in ovarian cancer. 
  Chapel Hill, NC - 1/1/2014
• "Cervical Cancer Screening: How did we get here?" 
  Memphis, TN - 1/1/2014
• "CREOG Review: Gynecologic Oncology" 
  University of Tennessee Health Science Center, Memphis, TN - 1/1/2014
• Comparison of robotic assisted and laparotomy recurrence rates in the staging and treatment of early stage endometrial cancer: a retrospective study. 
  University of Tennessee Health Science Center, Memphis, TN - 1/1/2013
• Keratosis reduces sensitivity of anal cytology in detecting anal intraepithelial neoplasia. 
  University of Tennessee Health Science Center, Memphis, TN - 1/1/2012
• Birth Weight Discordance and Lung Maturity in Triplet Births. 
  Maui, HI - 1/1/2009
• Phosphofructokinase Gene Regulation in Post-Implantation Mice Embryos. 
  University of Chicago, 2003; Anderson University, 2004; Anderson, IN, 2004 - 1/1/2004
• Join now to see all

Other

• Raising the bar on screening. 
  Salani, R, ElNaggar, A, View on the News, Ob.Gyn.News
  1/1/2015
• High resolution anoscopy for the detection of anal intraepithelial neoplasia. 
  ElNaggar, A., Likes, W., Robbins, D., & Thorpe, E., Obstetrics & Gynecology (Surgical Film)
  1/1/2014